(MedPage Today) — TORONTO — For some patients with multiple myeloma and their physicians, progression-free survival (PFS) is just as important as overall survival (OS), according to results from a cross-sectional survey.
In a survey across…
Source link : https://www.medpagetoday.com/meetingcoverage/ims/117546
Author :
Publish date : 2025-09-19 14:48:00
Copyright for syndicated content belongs to the linked Source.
